Triple Agent Therapy as a Novel Approach to Inflammatory Bowel Disease Treatment

被引：0
|
作者：
Thomas, Braden [1 ]
Zeineddine, Fadl [2 ]
Thurston, Theresa [3 ]
Moskow, Joshua [3 ]
Abraham, Bincy P. [4 ]
机构：
[1] Houston Methodist Hosp, Baltimore, MD USA
[2] Houston Methodist Hosp, Houston, TX USA
[3] Texas A&M Sch Med, Houston, TX USA
[4] Houston Methodist Weill Cornell, Houston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001045208.51693.de
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S3960
引用
收藏
页码：S2574 / S2574
页数：1
相关论文
共 50 条
  • [41] Andrographolide derivative as anti-inflammation agent for treatment of inflammatory bowel disease
    WANG Ying
    中国药理学与毒理学杂志, 2019, (10) : 763 - 764
  • [42] Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease
    Du, Yaoyao
    Rong, Lan
    Cong, Yuanhua
    Shen, Lan
    Zhang, Ning
    Wang, Bing
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (03) : 191 - 209
  • [43] Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy
    Kong, Chen
    Yang, Meifeng
    Yue, Ningning
    Zhang, Yuan
    Tian, Chengmei
    Wei, Daoru
    Shi, Ruiyue
    Yao, Jun
    Wang, Lisheng
    Li, Defeng
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5389 - 5413
  • [44] Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease
    Date, Abhijit A.
    Rais, Rana
    Babu, Taarika
    Ortiz, Jairo
    Kanvinde, Pranjali
    Thomas, Ajit G.
    Zimmermann, Sarah C.
    Gadiano, Alexandra J.
    Halpert, Gilad
    Slusher, Barbara S.
    Ensign, Laura M.
    JOURNAL OF CONTROLLED RELEASE, 2017, 263 : 132 - 138
  • [45] Liver fibrosis predicts response to advanced therapy in inflammatory bowel disease: a new personalized treatment approach?
    Bencardino, S.
    D'Amico, F.
    Bara, R.
    Allocca, M.
    Zilli, A.
    Furfaro, F.
    Parigi, T. L.
    Ungaro, F.
    Fiorino, G.
    Peyrin-Biroulet, L.
    Massimino, L.
    Danese, S.
    Moschetta, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2151 - i2152
  • [46] A novel approach for quantitative assessment of mucosal damage in inflammatory bowel disease
    Ismail I Matalka
    Faruq A Al-Omari
    Rola M Salama
    Alia H Mohtaseb
    Diagnostic Pathology, 8
  • [47] A novel approach for quantitative assessment of mucosal damage in inflammatory bowel disease
    Matalka, Ismail I.
    Al-Omari, Faruq A.
    Salama, Rola M.
    Mohtaseb, Alia H.
    DIAGNOSTIC PATHOLOGY, 2013, 8
  • [48] Hepatocyte growth factor: A novel approach to the management of inflammatory bowel disease
    Arthur, LG
    Kuenzler, KA
    Schwartz, MZ
    GASTROENTEROLOGY, 2003, 124 (04) : A791 - A791
  • [49] Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease
    Dahan, Arik
    Markovic, Milica
    Epstein, Svetlana
    Cohen, Noa
    Zimmermann, Ellen M.
    Aponick, Aaron
    Ben-Shabat, Shimon
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 108 : 78 - 85
  • [50] Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease
    Van Immerseel, Filip
    Ducatelle, Richard
    De Vos, Martine
    Boon, Nico
    Van De Wiele, Tom
    Verbeke, Kristin
    Rutgeerts, Paul
    Sass, Benedikt
    Louis, Petra
    Flint, Harry J.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (02) : 141 - 143
12345